Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

Recent & Breaking News (NYSEAM:ZOM)

Zomedica Announces Ongoing Equity Financing

GlobeNewswire March 7, 2017

Zomedica Pharmaceuticals Corp. Announces 2016 Year End Results

GlobeNewswire February 28, 2017

Zomedica Announces Stock Option Grant and Pending Share Issuances

GlobeNewswire February 24, 2017

Zomedica Appoints Robert DiMarzo as Executive Vice President of Global Strategy

GlobeNewswire February 23, 2017

Zomedica Launches Voice of the Vet™ Customer Engagement Program

GlobeNewswire January 31, 2017

Zomedica Announces Two Transdermal Products for Cats

GlobeNewswire January 30, 2017

Zomedica announces new research agreement

Stockhouse Editorial January 5, 2017

Zomedica Announces Research Agreement with Celsee Diagnostics for Cancer Liquid Biopsy

GlobeNewswire January 5, 2017

Zomedica to present at 2017 biotech conference

Stockhouse Editorial January 4, 2017

Zomedica Pharmaceuticals Corp. To Present at 2017 Biotech Showcase Conference

GlobeNewswire January 3, 2017

Zomedica Completes First Tranche Closing of Equity Financing

GlobeNewswire December 29, 2016

Zomedica Provides an Update on Equity Financing and Grants Stock Options

GlobeNewswire December 21, 2016

Zomedica Opens Investigational New Animal Drug Application with FDA Center for Veterinary Medicine for Anti-diarrheal Medication ZM-007

GlobeNewswire December 19, 2016

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2016 Financial Results

GlobeNewswire November 22, 2016

Zomedica Retains Renmark Financial Communications to Enhance Investor Outreach and Extends Equity Offering

GlobeNewswire November 7, 2016

Zomedica Announces Continuation of Aggregate C$15.0 Million Equity Financing

GlobeNewswire October 6, 2016

Zomedica Adds Two New Directors

Stockhouse Editorial October 4, 2016

Zomedica Appoints Two Animal Health Veterans to Board of Directors

GlobeNewswire October 4, 2016

Zomedica Graduates to Tier 1 of the TSX Venture Exchange

GlobeNewswire September 19, 2016

Zomedica (V.ZOM) raises over $5.0 mil in first tranche of equity financing

Stockhouse Editorial August 29, 2016